Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DN.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
DN.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DN.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DN.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DN.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DN.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.626EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.626EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.626ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.626ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.626EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.626EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.626ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.626ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.629EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.629EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.629ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.629ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.629EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.629EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.629ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.629ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.61 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.61 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.61 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.61 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.61 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.61 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.61 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.61 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-9785.9South Korea
BA.2.75.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17621Germany
BA.2.75.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.75.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.75.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.75.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GC.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used